Listed by the USPTO as HA, JULIE
Tech Center 1600 • Art Units: 1647 1654 1658 1675
This examiner grants 76% of resolved cases
HA, JULIE is a USPTO patent examiner in tech center 1600 and art unit 1647. The profile covers 1124 resolved cases, with an allowance rate of 75.7% and an interview lift of 44.1%. The median time to allowance is 952 days. The substantial case volume supports using the allowance measure as a meaningful historical signal, showing that a majority of cases reached allowance. The interview measure indicates a strong positive association with allowance outcomes, while the median timeline supports structured prosecution planning.
The named companies are The Regents of the University of California, Uif (university Industry Foundation), Yonsei University, and Eli Lilly and Company. The named firms are BALLARD SPAHR LLP, Knobbe, Martens, Olson & Bear, LLP, and NOVICK, KIM & LEE, PLLC, dba NKL Law. The portfolio includes university and pharmaceutical work. Practitioners may benefit from early interview preparation, technically precise amendments, and careful preservation of supported claim scope.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18726124 | POLYPEPTIDE AND APPLICATION THEREOF IN PREPARATION OF ANTI-FIBROSIS DRUG | Non-Final OA | Zhejiang University |
| 18292207 | BARRIER FUNCTION PRESERVING PEPTIDES FOR MEMBRANES | Non-Final OA | The Regents of the University of California |
| 18518981 | Treatment of Glaucoma by Neuroprotection | Non-Final OA | The Regents of the University of California |
| 17442831 | COMPOSITIONS AND METHODS OF TREATING AND PREVENTING SYSTEMIC COMPLICATIONS OF ACUTE ILLNESS | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 18174158 | METHODS, SYSTEMS, AND COMPOSITIONS FOR LEGUME-BASED PRODUCTION OF THERAPEUTIC PROTEINS AND THERAPEUTIC MEDICAL MATERIALS | Non-Final OA | Arizona Board of Regents on Behalf of The University of Arizona |
| 18724295 | PEPTIDE HAVING ACTIVITY OF IMPROVING STATE OF SKIN, AND USE THEREOF | Non-Final OA | CAREGEN CO., LTD. |
| 17609731 | A METHOD OF DECREASING CONCENTRATION OF TAU (T) PROTEIN AND/OR PHOSPHORYLATED TAU (T) PROTEIN | Non-Final OA | UNIVERSITY OF THE WITWATERSRAND, JOHANNESBURG |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy75.7% of resolved applications examined by Julie Ha were allowed (1,124 resolved cases), compared with 39.7% across Art Unit 1647 over the last five years.
This examiner's interview lift is +44.1 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Julie Ha took 952 days on average from filing to allowance.
Julie Ha examines applications in Art Unit 1647 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
